ALYSSA RACE: Open Payments
NPI 1538761903 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,259 in 59 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,259
Food & beverage: $1,259
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $203 |
| JAZZ PHARMACEUTICALS INC. | 7 | $163 |
| Neurocrine BioSciences, Inc. | 7 | $154 |
| Teva Pharmaceuticals USA, Inc. | 5 | $119 |
| Lundbeck LLC | 5 | $112 |
| ARGENX US, INC. | 4 | $93 |
| PFIZER INC. | 3 | $72 |
| TG Therapeutics, Inc. | 2 | $60 |
| SK Life Science, Inc. | 3 | $52 |
| Genentech USA, Inc. | 2 | $44 |
Products named: EPIDIOLEX, INGREZZA, AUSTEDO XR, VYEPTI, Nayzilam, VYVGART HYTRULO, NURTEC ODT, BRIUMVI.
Industry payments across OK — which companies pay providers there.
